Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-27

Clinical Trial Update: Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia [Phase 3]

View source ↗

Summary

Phase 3 trial results comparing intravenous iron carboxymaltose, isomaltoside, and oral iron sulfate for postpartum anemia have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Iron Sulfate (ferrous sulfate)
  • iron carboxymaltose (iron carboxymaltose)
  • isomaltoside (iron isomaltoside)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Postpartum Anemia Nos, Iron-deficiency | Phase 3 | Status: COMPLETED